Back to Search Start Over

Large-vessel vasculitis diagnosed between 50 and 60 years: Case-control study based on 183 cases and 183 controls aged over 60 years.

Authors :
Delaval L
Daumas A
Samson M
Ebbo M
De Boysson H
Liozon E
Dupuy H
Puyade M
Blockmans D
Benhamou Y
Sacré K
Berezne A
Devilliers H
Pugnet G
Maurier F
Zénone T
de Moreuil C
Lifermann F
Arnaud L
Espitia O
Deroux A
Grobost V
Lazaro E
Agard C
Balageas A
Bouiller K
Durel CA
Humbert S
Rieu V
Roriz M
Souchaud-Debouverie O
Vinzio S
Nguyen Y
Régent A
Guillevin L
Terrier B
Source :
Autoimmunity reviews [Autoimmun Rev] 2019 Jul; Vol. 18 (7), pp. 714-720. Date of Electronic Publication: 2019 May 04.
Publication Year :
2019

Abstract

Background: Age at onset of large-vessel vasculitis (LVV) is commonly used to distinguish giant cell arteritis (GCA) and Takayasu arteritis (TA). However, LVV between age 50 and 60 years may be difficult to classify.<br />Methods: We conducted a retrospective study including LVV aged between 50 and 60 years at onset (LVV <subscript>50-60</subscript> , cases) and compared them to LVV aged over 60 years (LVV <subscript>>60</subscript> , controls). LVV was defined histologically and/or morphologically. Controls fulfilled ACR 1990 criteria for GCA or presented isolated aortitis.<br />Results: We included 183 LVV <subscript>50-60</subscript> and 183 gender-matched LVV <subscript>>60</subscript> . LVV <subscript>50-60</subscript> had more frequent peripheral limb manifestations (23 vs. 5%), and less frequent cephalic (73 vs. 90%) and ocular signs (17 vs. 27%) than LVV <subscript>>60</subscript> . Compared to LVV <subscript>>60</subscript> , CT angiography and PET/CT scan were more frequently abnormal in LVV <subscript>50-60</subscript> (74 vs. 38%, and 90 vs. 72%, respectively), with aorta being more frequently involved (78 vs. 47%). By multivariate analysis, absence of cephalic symptoms, presence of peripheral limb ischemia and aorta involvement, and increased CRP level were significantly associated with LVV <subscript>50-60</subscript> presentation compared to LVV <subscript>>60</subscript> . At last follow-up, compared to LVV <subscript>>60</subscript> , LVV <subscript>50-60</subscript> received significantly more lines of treatment (2 vs. 1), more frequent biologics (12 vs. 3%), had more surgery (10 vs. 0%), and had higher prednisone dose (8.8 vs. 6.5 mg/d) at last follow-up, CONCLUSION: LVV onset between 50 and 60 years identifies a subset of patients with more frequent aorta and peripheral vascular involvement and more refractory disease compared to patients with LVV onset after 60.<br /> (Copyright © 2019. Published by Elsevier B.V.)

Details

Language :
English
ISSN :
1873-0183
Volume :
18
Issue :
7
Database :
MEDLINE
Journal :
Autoimmunity reviews
Publication Type :
Academic Journal
Accession number :
31059846
Full Text :
https://doi.org/10.1016/j.autrev.2019.05.008